{"id":415929,"date":"2021-01-15T14:09:58","date_gmt":"2021-01-15T19:09:58","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=415929"},"modified":"2021-01-15T14:09:58","modified_gmt":"2021-01-15T19:09:58","slug":"association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/","title":{"rendered":"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19"},"content":{"rendered":"<div class=\"mw_release\">\n<p>TUCSON, Ariz., Jan.  15, 2021  (GLOBE NEWSWIRE) &#8212; The National Institutes (NIH) has issued a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Aek_bzEWp7vFJ94z1z7HIlN6ttzdtpJNVVFVm9qJ13m3D6MjjBW_iDYDWMdQHyJgTo_p--GuR9KOHxJIHieVeezcIQ-pnTAOzdO4OlCfm7Rwm5yfQYij5l4PnOhq8xHJ\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">new statement<\/a> on the use of the anti-parasitic drug ivermectin for the treatment of COVID-19. Previously, it recommended against this treatment, but now states that its Panel \u201chas determined that there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19.\u201d<\/p>\n<p>The Association of American Physicians and Surgeons (AAPS) notes that there are now 49 ivermectin studies summarized on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pyC_QJgBUbe7tXzvGFpfPLWhsw6Kbasy-3RARgHMcgX1m_Rdty0CpouJWvfQ_sFsV06xrs8aiFXzlvChE-Mxfg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">c19study.com<\/a>, 100 percent of which show favorable results. In contrast, there are very few studies of the antibody cocktails now being used under an Emergency Use Authorization.<\/p>\n<p>NIH concludes from its current analysis that \u201cresults from adequately powered, well-designed, and well-conducted clinical trials are needed to provide further guidance on the role of ivermectin in the treatment of COVID-19.\u201d<\/p>\n<p>The NIH may be responding to requests related to the testimony strongly favoring ivermectin in <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UGkjFLTwOFRxfDWHYZ1Jr6v31760AE_bZptpy0ZECDC7APiWGQv_DGl6m7kNCXmRzopZEww3a5bgnBGosdSRA9gf2MjUEiwkleYR_xSEtkDam5tgnhz0RwF6rBlRgAnWhcWwzqQEnvj5K3hu93K-ddVLRx4ZqQwuYTfBTAbFFeJQ_w3FcEJwsSXSSufLawQPS_On-6LJX-21XY3R-lhp9Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">a Dec 8 Senate hearing<\/a> before the Committee on Homeland Security and Governmental Affairs. <\/p>\n<p>While awaiting further studies, patients are dying, AAPS points out. More than a billion doses of this very safe drug have been administered since 1981. Yet many medical facilities and many physicians refuse to prescribe it for COVID-19, citing NIH guidance.<\/p>\n<p>\u201cPerhaps with this change, patients won\u2019t need a court order to get a lifesaving drug,\u201d stated AAPS executive director Jane Orient, M.D. A patient in Buffalo, who was dying on a ventilator, had a dramatic turnaround when family members persuaded an intensive care doctor to prescribe ivermectin. But doctors refused to allow further doses when her condition declined. State Supreme Court <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xtlqR_VQcErVo2I2DRrpp8S8SwRPt2Qb3lDYuiklpjJldXv3N_p1coLKyNFC2fIzMEny_Jjau_GAnhDsF795Y5V4rhwasKHAO8LijOuC5X-myS6YqIJX_FshZu4HLSnbomZOQfKiUlIoqYDc3KZxuviOa4zhc9V3DM3D6-z0EZN84qOhNGYdBH0yaEcJLOb-oa6OLL-rD6bp2YSjg3VpylveiYKSYunszgGCzCK8VWKtWAMijL2X_kuVSexeCMbR-JeaWc4IJ3cRQyg5AVTBp9mhTRu4p-ibiG5MQc3PCWRCmOnefRvzfyqH-erEiAmiKuSNOhA4JzAJNZqJ0wYT8w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Judge Henry A. Nowak ordered the drug to be re-started<\/a>, and the patient again improved.<\/p>\n<p>\u201cOnce a drug is approved, it may be lawfully used for new indications, and at least 20 percent of prescriptions are for \u2018off-label\u2019 uses,\u201d Dr. Orient stated. \u201cTo have a doctor withdraw a drug that appears to be saving a patient\u2019s life, because a federal bureaucracy thinks it hasn\u2019t been studied enough for that use, is shocking to those who believe in the traditional ethic of Hippocrates.\u201d<\/p>\n<p>The <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fNQG3NkCEUdyvPZ8SpuDCL6FHNZqWweTcd9w66jYuZAeLjl4AHLc6V7dnWG0xp3FC_TwkKq8UMxVJCubt1Jw605OXnOhuEFKVWr2EUYBrkwGI8vUZS20sOf7jwBSpwwHhqcuFzW-04hyN1V6CqbkPg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Association of American Physicians and Surgeons (AAPS)<\/a> has represented physicians in all specialties nationwide since 1943. It provides information on early home treatment for COVID-19. Its motto is <em>omnia pro aegroto<\/em> (everything for the patient).<\/p>\n<p>Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/5a69e07d-31f8-447d-939b-151cc7e488ce\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TUCSON, Ariz., Jan. 15, 2021 (GLOBE NEWSWIRE) &#8212; The National Institutes (NIH) has issued a new statement on the use of the anti-parasitic drug ivermectin for the treatment of COVID-19. Previously, it recommended against this treatment, but now states that its Panel \u201chas determined that there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19.\u201d The Association of American Physicians and Surgeons (AAPS) notes that there are now 49 ivermectin studies summarized on c19study.com, 100 percent of which show favorable results. In contrast, there are very few studies of the antibody cocktails now being used under an Emergency Use Authorization. NIH concludes from its current analysis that \u201cresults from adequately powered, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-415929","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TUCSON, Ariz., Jan. 15, 2021 (GLOBE NEWSWIRE) &#8212; The National Institutes (NIH) has issued a new statement on the use of the anti-parasitic drug ivermectin for the treatment of COVID-19. Previously, it recommended against this treatment, but now states that its Panel \u201chas determined that there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19.\u201d The Association of American Physicians and Surgeons (AAPS) notes that there are now 49 ivermectin studies summarized on c19study.com, 100 percent of which show favorable results. In contrast, there are very few studies of the antibody cocktails now being used under an Emergency Use Authorization. NIH concludes from its current analysis that \u201cresults from adequately powered, &hellip; Continue reading &quot;Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-15T19:09:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19\",\"datePublished\":\"2021-01-15T19:09:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/\"},\"wordCount\":413,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/\",\"name\":\"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=\",\"datePublished\":\"2021-01-15T19:09:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19 - Market Newsdesk","og_description":"TUCSON, Ariz., Jan. 15, 2021 (GLOBE NEWSWIRE) &#8212; The National Institutes (NIH) has issued a new statement on the use of the anti-parasitic drug ivermectin for the treatment of COVID-19. Previously, it recommended against this treatment, but now states that its Panel \u201chas determined that there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19.\u201d The Association of American Physicians and Surgeons (AAPS) notes that there are now 49 ivermectin studies summarized on c19study.com, 100 percent of which show favorable results. In contrast, there are very few studies of the antibody cocktails now being used under an Emergency Use Authorization. NIH concludes from its current analysis that \u201cresults from adequately powered, &hellip; Continue reading \"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-15T19:09:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19","datePublished":"2021-01-15T19:09:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/"},"wordCount":413,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/","name":"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=","datePublished":"2021-01-15T19:09:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc4NCMzOTIxNTgxIzIwMjE4NzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/association-of-american-physicians-and-surgeons-aaps-applauds-nih-revised-stance-on-ivermectin-for-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Association of American Physicians and Surgeons (AAPS) Applauds NIH Revised Stance on Ivermectin for COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/415929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=415929"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/415929\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=415929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=415929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=415929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}